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According to the literature, sex differences exist in
many health issues, including metabolic diseases.
For example, men have been identified as more likely
to suffer from obesity, have diets low in fruit and veg-
etables, and have unhealthy behaviors, resulting in
specific diseases [1–4]. Research in the United States
demonstrated that lifestyles and psychosocial factors
were related to body weight changes, and that these
had marked differential sex effects [5]. Sex differences
in disease formation mediated by disparities of life-
styles have also been demonstrated [6]. However,
there have been few studies of the relationships among
sex, lifestyles and metabolic diseases in Asian popu-
lations, and the findings have been equivocal [7,8].
Hypertension, hyperlipidemia and diabetes have
been increasing in incidence across the globe and have
been the focus of much research interest [9,10]. The
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factors contributing to hypertension, hyperlipidemia
and diabetes, such as the relationship between choles-
terol (Chol) diet and serum Chol levels, has been
debated in the literature [11–14]. Controversy remains
over whether or not an unhealthy lifestyle results in 
the development of diabetes, hyperlipidemia and
hypertension [15–18].
Little is known about the relationships among sex,
biochemical profile, metabolic disease and lifestyle,
especially in normal Asian populations. In this study,
we report the results of a nationwide, population-
based study in Taiwan, and assess the overall risk
factors. The aims of this cross-sectional study in a nor-
mal population were: first, to compare the differences
in physical and metabolic characteristics between dif-
ferent the sexes; second, to compare the differences in
prevalences of diabetes, hyperlipidemia, and hyper-
tension between different sexes; third, to compare the
differences in lifestyles between the sexes; and finally
to clarify the determinants of diabetes, hyperlipidemia,
and hypertension in a Taiwanese population.
MATERIALS AND METHODS
Data acquisition
Data were obtained from the Project of Surveillance
for diabetes, hyperlipidemia, and hypertension in
Taiwan. This was a cross-sectional study on health,
health behavior, and disease status of stratified selected
subjects in Taiwan from March 1, 2002 to October 30,
2002, performed by the Taiwan Bureau of Health Pro-
motion [19]. General population was defined as citi-
zens of Taiwan registered by household. The detailed
selection methods are available in the report of Project
of Surveillance for diabetes, hyperlipidemia, and
hypertension in Taiwan [19]. The selection design was
briefly as follows: (1) 68 townships were randomly
selected in proportion to the 359 nationwide townships
in the seven major areas in Taiwan; (2) 8–44 “lin”
(smaller units than towns) were selected from each
township, based on population size; and (3) four eli-
gible household respondents were selected from each
selected lin by systematic stratified random sampling.
Well-trained interviewers (public health nurses)
administered face-to-face structured interviews. In-
terview appointments were made by phone prior to
interviews being conducted. Participating subjects
were told not to eat on the morning of the day of the
interview. Fasting blood samples (no food intake for
at least 8 hours) were taken in the morning and hep-
arinized blood samples were centrifuged at 2,000 rpm
for 20 minutes at 4°C, within 4 hours of drawing.
Serum was separated and stored in aliquots at −20°C
and transported to the laboratory center of the Bureau
of Health Promotion in a −20°C to −40°C environ-
ment. Demographic information and information on
lifestyles, including exercise and dietary habits, and
medical and drug histories were collected by question-
naires conducted by the interviewers at the same time.
Regular exercise was defined as more than three times
a week, for more than 30 minutes each time, and reach-
ing more than 130 heart beats/minute on each occa-
sion. Dietary habit was assessed using a structured
questionnaire composed of 14 questions and modi-
fied for use in a Chinese context for subjects residing in
Taiwan, employing the Nutrition and Health Survey
in Taiwan (NAHSIT) [19]. The characteristics of nutri-
tional components were identified and demonstrated
in the reports [19]. For instance, a high-Chol diet was
defined based on four criteria: (1) eating meat with fat
or skin; (2) the frequency of eating egg yolks; (3) the
frequency of lard use; and (4) the frequency of gravy
use. Blood pressure (BP) (sitting position, rest for at
least 10 minutes, repeat measurement), pulse, waist
and hip circumferences were also examined following
the standard procedures translated from the WHO
guidelines [20,21]. BP was measured for a third time
if the difference between the first two measurements
was > 10 mmHg. The average of the two closer meas-
urements was then used as the final BP measurement.
Blood tests
Blood parameters measured included fasting blood
sugar (AC sugar), glycosylated hemoglobin, uric acid
(UA), blood urea nitrogen (BUN), creatinine, total
Chol, high-density lipoprotein, low-density lipopro-
tein, triglyceride (TG), apolipoprotein-A1 (ApoA1),
apolipoprotein-B (ApoB), glutamate oxaloacetate tra-
nsaminase (GOT), and glutamate pyruvate transami-
nase (GPT). AC sugar, Chol, and TG levels were
measured by colorimetry, glycosylated hemoglobin
was detected using high performance liquid chro-
matography, high-density lipoprotein was detected
by electrophoresis, and ApoA1 and ApoB were
detected by immunoturbidimetric tests. We defined
abnormal results according to the standards of JNC VI
(The Sixth Report of the Joint National Committee on
Prevention, Detection, Evaluation and Treatment of
High Blood Pressure), the American Diabetes Associa-
tion, and NCEP-ATP III (National Cholesterol Educa-
tion Program, Adult Treatment Panel III Framingham
Point Scores). Hypertension was defined as systolic
BP > 140 mmHg or diastolic BP > 90 mmHg. Subjects
who had been prescribed antihypertensive medica-
tion or had taken antihypertensive drugs were also
defined as having hypertension. Patients with AC
sugar > 126 mg/dL or those who had taken oral
antidiabetic agents were defined as having diabetes.
Hypercholesterolemia was defined as a blood Chol
level of ≥ 240 mg/dL, and hypertriglyceridemia was
defined as a blood TG level of ≥ 200 mg/dL. Subjects
who had taken cholesterol-lowering or triglyceride-
lowering medication for hyperlipidemia were also
defined as hyperlipidemic.
Statistical analysis
Data were analyzed by comparing means using de-
scriptive statistics such as t tests, χ2 tests, and logistic
regression analysis. SPSS version 14.0 (SPSS Inc.,
Chicago, IL, USA) was used and two-tailed p values
of < 0.05 were considered statistically significant.
RESULTS
A total of 7,578 subjects completed the interviews.
Blood samples were obtained from 6,602 subjects and
blood pressure information was available for 6,941 sub-
jects. Overall, 6,600 subjects (87.1%) fulfilled the study
criteria and were included in the final analysis, of which
3,435 (52%) were females. Table 1 shows the charac-
teristics of the study participants. Their ages ranged
from 15.6 to 95.0 years, with a mean age of 43.0 ± 16.9
years (male, 43.07 ± 17.31 years; female, 43.01 ± 16.49
years), and a median age of 41.7 years. There were sex
differences in systolic BP, with an average of 118.89 ±
16.5 mmHg for males and 112.36 ± 18.95 mmHg for
females (p < 0.001). Males had a slightly higher mean
diastolic BP than females (77.8 vs. 72.3 mmHg), though
this did not reach statistical significance. There was a
significant difference in hip circumferences between
males and females (mean, 97.0 ± 7.7 vs. 96.0 ± 8.3 cm,
p = 0.001). With regard to biochemical parameters, sex
differences were detected in serum levels of TG,
ApoA1, GOT, GPT, creatinine, and UA (p < 0.001).
The numbers of each sex with diabetes, hyperlipi-
demia, and hypertension are shown in Table 2. The
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Table 1. Comparison of characteristics of male and female subjects recruited from the normal population*
Male (n = 3,165) Female (n = 3,435) p†
Physiological characteristics
Age (yr) 43.07 (17.31) 43.01 (16.49) 0.893
Systolic BP (mmHg) 118.89 (16.46) 112.36 (18.95) < 0.001
Diastolic BP (mmHg) 77.77 (10.96) 72.30 (10.93) 0.688
Waist circumference (cm) 84.19 (10.62) 75.64 (10.43) 0.272
Hip circumference (cm) 97.01 (7.70) 96.02 (8.28) 0.001
WHR 0.87 (0.08) 0.79 (0.07) 0.251
Biochemical characteristics
Fasting sugar (mg%) 94.99 (29.11) 93.94 (28.46) 0.168
HbA1C (%) 5.38 (1.05) 5.34 (1.06) 0.428
Cholesterol (mg/dL) 182.30 (37.90) 184.41 (37.95) 0.245
HDL (mg/dL) 51.26 (14.77) 58.86 (14.26) 0.064
LDL (mg/dL) 116.04 (27.09) 114.50 (27.33) 0.346
Triglyceride (mg/dL) 142.31 (95.71) 113.03 (72.69) < 0.001
ApoA1 (mg/dL) 136.92 (22.98) 150.76 (24.99) < 0.001
ApoB (mg/dL) 91.63 (25.22) 85.95 (25.17) 0.713
GOT (IU/L) 23.24 (19.49) 18.89 (14.50) < 0.001
GPT (IU/L) 23.10 (18.43) 17.84 (12.75) < 0.001
BUN (mg/dL) 14.91 (4.65) 13.45 (4.50) 0.056
Creatinine (mg/dL) 1.04 (0.28) 0.80 (0.32) < 0.001
Uric Acid (mg/dL) 7.23 (1.68) 5.55 (1.51) < 0.001
*Data presented as mean (standard deviation); †t test. BP = blood pressure; WHR = waist-to-hip ratio; HbA1C = glycosylated 
hemoglobin; HDL = high-density lipoprotein; LDL = low-density lipoprotein; ApoA1 = apolipoprotein-A1; ApoB = apolipoprotein-B;
GOT = glutamate oxaloacetate transaminase; GPT = glutamate pyruvate transaminase; BUN = blood urea nitrogen.
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prevalences of diabetes, hyperlipidemia (hypercho-
lesterolemia or hypertriglyceridemia), and hyperten-
sion were 9.9%, 22.8%, and 15.7%, respectively. The
prevalences of diabetes, mixed hyperlipidemia, and
hypertension in males were 10.0%, 27.0%, and 19.2%,
respectively; these were slightly higher than in females
(9.9%, 19.0%, and 12.4%, respectively).
Differences in lifestyles between the sexes are
shown in Table 3. More than one quarter (856/3,165) of
males had regular exercise habits. However, only one
fifth (725/3,436) of females reported regular exercise
habits. However, males were more likely to have bad
diets that were fat- and Chol-rich, compared with
females (p < 0.001).
Adjusted logistic regression models (Table 4) were
used to analyze the relationships between potential
predictive factors (sex, age, waist-to-hip ratio [WHR],
biochemical parameters, and lifestyle) and disease
(diabetes, hyperlipidemia, and hypertension) (data not
shown). Overall, the results showed that sex, age, waist
circumferences and WHR were significantly associ-
ated with diabetes, hyperlipidemia, and hypertension,
but that dietary habits and regular exercise habits had
little effect (data not shown). Models for diabetes,
hyperlipidemia, and hypertension separated by sex
were further analyzed (Table 4). Age, WHR, AC
sugar, Chol, TG, ApoB, and UA were highly associated
with diabetes, hyperlipidemia, and hypertension in
both sexes to greater or lesser extents, but exercise and
diet habits had lesser effects on diabetes, hyperlipi-
demia, and hypertension.
DISCUSSION
The overall prevalence of diabetes in our study was
9.9%. The prevalences of diabetes were 6.6% in an
adult population in France in 1985 [22], 6.5% in
Argentina in 1998 [23], 6.9% in Vietnam in 2001 [24],
6.8% in Japan in 2002 [25], 6–10% in different states in
the US in 2001 [26], and 9.5% in Nepal before 2007
[27]. The prevalences in different countries therefore
vary, but Taiwan seems to have a higher prevalence
than other Asian countries, approaching that of the
US. This could be due to the high-calorie, Western
diet that has become popular in Taiwan in recent
decades. This suggests a need for public screening
for diabetes in Taiwan. No difference in prevalence of
diabetes between males and females was found in
our subjects.
The overall prevalence of hyperlipidemia in our
study was 22.8%, which is lower than in other coun-
tries, including 24–36% in Argentina in 1998 [23] and
31–35% in China in 2004 [28]. This would be expected
to result in a lower prevalence of cerebral and cardio-
vascular diseases in Taiwan. However, a difference in
Table 2. Prevalences of diabetes, hyperlipidemia, and hypertension in males and females*
Total (n = 6,600) Male (n = 3,165) Female (n = 3,435) p†
Diabetes 656 (9.9) 317 (10.0) 339 (9.9) 0.869
Hyperlipidemia 1,506 (22.8) 855 (27.0) 651 (19.0) < 0.001
Hypertension 1,035 (15.7) 608 (19.2) 427 (12.4) < 0.001
*Data presented as n (%); †χ2 test (comparisons between males and females).
Table 3. Comparisons of exercise and dietary habits between males and females*
Male (n = 3,165) Female (n = 3,435) p†
Exercise
Regular exercise habit 856 (27.0) 725 (21.1) < 0.001
Heavy exerciser 650 (20.5) 452 (13.2) < 0.001
Diet
Fat-rich diet (ate meat with skin frequently) 1,790 (56.6) 1,204 (35.1) < 0.001
Cholesterol-rich diet 513 (16.2) 203 (5.9) < 0.001
Ate greens every day 788 (24.9) 963 (28.0) 0.004
Ate organic vegetables frequently 22 (0.7) 30 (0.9) 0.486
*Data presented as n (%); †χ2 test (comparisons between males and females).
Sex influences metabolic morbidities
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prevalence of hyperlipidemia was found between
sexes (27.0% in males and 19.0% in females). Fat- and
Chol-rich diets were also recorded more often in males,
suggesting that dietary habits might contribute to the
high prevalence of hyperlipidemia in males. Health
education, including information on healthy diets,
should be provided for the general population in
Taiwan.
The prevalence of hypertension in our study was
15.7%, including 19.2% of males and 12.4% of females.
This was slightly lower than in other countries, with
reported prevalences of 15.5% in Spain in 2005 (adults
aged over 15 years) [29], 37.8% in Liaoning Province in
China between 2005 and 2007 (adults aged over 35
years, rural population) [30], 39.1% in the Czech pop-
ulation in 2000 (general population, aged 25–64 years)
[31], and 28–44% in Argentina in 1998 (aged 20 years
and over) [23]. The prevalence in males in our study
was significantly higher than that in females (19.2% >
12.4%, p < 0.001). Males in the current study also had
higher systolic BP than females (118.89 mmHg >
112.36mmHg). Age-adjusted multiple linear regression
(data not shown) also revealed that the average male
systolic BP was 6.50 mmHg, which was higher than in
females [95% confidence interval (CI): 5.76–7.24].
Although previous studies have reported equivocal
results regarding sex differences in BP [32,33], the
results of our study demonstrated higher average
systolic BP and higher prevalence of hypertension in
males than females. These factors are associated with
increased risks of cerebral and cardiovascular diseases
and should thus be taken into consideration by public
health practitioners.
Sex differences in ApoA1 were also found in our
study (males 136.9 < females 150.8 mg/dL, p < 0.001).
ApoA1 is the primary protein component of high-
density lipoprotein particles and has been hypothe-
sized to play a key role in reducing the cholesterol
content of lipid-rich lesions [34]. Growing evidence
supports apolipoprotein levels, rather than standard
lipid and lipoprotein levels, as a better marker for
predicting vascular diseases. Our results indicating
higher ApoA1 level in females may partially explain
the lower prevalences of hyperlipidemia and hyper-
tension in females.
The causal relationships were clarified by cross-
sectional study. It was possible that the occurrence of
disease (e.g. hyperlipidemia or hypertension) forced
the subjects to modify their dietary habits. For instance,
we identified significant associations between male
diabetes and male hyperlipidemia, and the consump-
tion of organic vegetables. An overt difference in the
consumption of organic vegetables between females
and males was identified and could be attributed to
different coping methods used by males and females
for dealing with diabetes or hyperlipidemia. Thus, the
occurrence of diabetes or hyperlipidemia was the
cause, and eating organic vegetables was a resultant
outcome in the male, but not in the female population.
We further analyzed the contributions of various
independent factors to diabetes, hyperlipidemia, and
hypertension. In diabetes, WHR [odds ratio (OR): 1.07;
95% CI: 1.05–1.09] in females contributed more than in
males, whereas age (OR: 1.04; 95% CI: 1.03–1.05) con-
tributed more in males than in females. With regard to
hyperlipidemia, age (OR: 1.02; 95% CI: 1.01–1.03),
ApoB (OR: 1.06; 95% CI: 1.05–1.07), and UA (OR: 1.18;
95% CI: 1.10–1.27) contributed more in females than in
males, whereas WHR (OR: 1.05; 95% CI: 1.04–1.07)
and creatinine level (OR: 1.02; 95% CI: 1.16–2.82) con-
tributed more in the male population.
The prevalences of hyperlipidemia and hyperten-
sion were significantly higher in males than in females.
A previous study illustrated that there was a sex differ-
ence in the overall prevalence of metabolic syndrome
in Taiwan (20.4% of men and 15.3% of women), the age
at appearance of the first isolated component (mean
age, 43.3 years in women vs. 45.6 years in men), the
mean age for development of metabolic syndrome
(mean age, 51.3 years in men vs. 56.2 years in women),
and the period from the appearance of any isolated
component to the development of metabolic syndrome
(12.8 years in men vs. 5.7 years in women) [35].
Another study from the US also demonstrated that the
prevalence and extent of coronary artery calcification
were higher in men compared with women in the same
age group [36]. The results of our study were consistent
with this conclusion that women may develop cardio-
vascular diseases later in life than men.
In conclusion, differences between the sexes exist in
physical characteristics, biochemical parameters, life-
styles, and metabolic diseases in Taiwan. Sex could
influence the occurrence of hypertension, hyperlipi-
demia, and diabetes. We suggest that medical practi-
tioners be aware of the fact that the sexes show
variations in morbidities due to metabolic diseases,
and they should thus provide suitable interventions
for the high-risk patients.
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三高盛行率之性別差異：
飲食及運動是否影響三高盛行率？
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我們進行一個台灣全國人口為基礎的抽樣研究以了解不同性別間生理及生化指標、飲
食及運動習慣、以及糖尿病、高血脂症、及高血壓盛行率的差異性，並進ㄧ步釐清影
響三高的因素。2002年由全國人口中分層隨機抽樣 7,578 位個案進入台灣居民健康
普查研究。嚴格受訓的訪員進行包括身體組成、抽血、人口學資料、飲食及運動習
慣、及疾病和藥物史的調查和測量。6,600 個案 (87.1%) 完成完整的調查和測量，年
齡分布為 15.6 to 95.0歲。糖尿病、高血脂症、及高血壓盛行率為 9.9%， 22.8%， 和 
15.7%，而男性高血脂症 (27.0%)及高血壓 (19.2%)盛行率高於女性。男性之高脂肪
飲食習慣及高膽固醇飲食習慣盛行率較高於女性。雖然高血脂症及高血壓盛行率男性
高於女性，然而標準化 logistic regression 分析在標準化年齡、性別、腰臀比、血
糖、血液膽固醇、三酸甘油脂、脂蛋白 A1、脂蛋白 B、肝功能、肌肝酸、尿酸、及血
壓之後，顯示飲食和運動習慣對於三高的影響程度不大。
關鍵詞：糖尿病，高血脂症，高血壓，性別差異
(高雄醫誌 2009;25:647–55)
